Skip to content

Drug interactions

Liposomal doxorubicin + Streptozocin

Severity: Moderate

Liposomal doxorubicin and Streptozocin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Streptozocin has been reported to prolong doxorubicin half-life, potentially increasing its toxicity. Both drugs can also cause toxicity on their own, notably myelosuppression and cardiac or renal effects.

What this interaction means in plain words

Liposomal doxorubicin and Streptozocin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Streptozocin may reduce doxorubicin metabolism, but the mechanism is not firmly established.

What to do

Monitor blood counts, cardiac function and renal function. Consider reducing the doxorubicin dose if toxicity appears.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Liposomal doxorubicin and Streptozocin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Liposomal doxorubicin with Streptozocin?

MediHelp rates the interaction as moderate. Liposomal doxorubicin and Streptozocin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Streptozocin has been reported to prolong doxorubicin half-life, potentially increasing its toxicity. Both drugs can also cause toxicity on their own, notably myelosuppression and cardiac or renal effects.

How serious is the interaction between Liposomal doxorubicin and Streptozocin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts, cardiac function and renal function. Consider reducing the doxorubicin dose if toxicity appears.

What other medicines interact with Liposomal doxorubicin?

MediHelp also lists interactions of Liposomal doxorubicin with, for example, Dengue vaccine, Belatacept, Cyclosporine. The full list is on the Liposomal doxorubicin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in